B-CELL LYMPHOBLASTIC LYMPHOMA
Clinical trials for B-CELL LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental CAR t therapy targets tough leukemia in first human trial
Disease control OngoingThis early-phase study tests a new type of immunotherapy called BAFFR-CAR T cells for adults with B-cell acute lymphoblastic leukemia that has come back or not responded to at least two prior treatments. The therapy involves reprogramming a patient's own immune cells to recognize…
Matched conditions: B-CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: PeproMene Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug combo shows promise in early trial for tough blood cancer
Disease control OngoingThis early-phase study tests whether combining two drugs, venetoclax and inotuzumab ozogamicin, is safe and effective for people with B-cell acute lymphoblastic leukemia (B-ALL), a fast-growing blood cancer. About 23 adults whose cancer has returned or not responded to treatment …
Matched conditions: B-CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Adult leukemia patients get Kid-Style chemo combo in new trial
Disease control OngoingThis phase 2 trial is testing whether a combination of chemotherapy drugs typically used in children can be safe and effective for adults aged 18 to 60 with newly diagnosed Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). The study aims to see if this 'pediatr…
Matched conditions: B-CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 18:20 UTC